Skip to main content
BDX
NYSE Industrial Applications And Services

Becton Dickinson Launches $1.6 Billion Debt Tender Offer

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$171.68
Mkt Cap
$48.913B
52W Low
$127.536
52W High
$184.943
52W Position info
35% above low
Off High info
7.2% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

BDX sits 35% above its 52-week low of $127.536.

Summary

Becton Dickinson announced a tender offer to repurchase up to $1.6 billion of its outstanding debt securities, optimizing its capital structure following a recent spin-off and cash infusion.


Key Events · Financing and Capital Events · BDX

  • Tender Offer Commencement

    Becton Dickinson initiated tender offers to purchase for cash up to $1.6 billion of its outstanding debt securities.

  • Debt Series Included

    The offer targets 15 different series of senior notes and debentures with varying maturities and acceptance priority levels.

  • Strategic Capital Management

    This move follows the recent spin-off of its Biosciences & Diagnostic Solutions business, which generated $4 billion in cash, and aligns with the company's capital allocation strategy, including a $2 billion share repurchase program.

  • Early Tender Deadline

    Holders tendering by February 24, 2026, are eligible to receive an early tender payment in addition to the total consideration.


Analysis · BDX · Industrial Applications And Services

This significant debt tender offer demonstrates Becton Dickinson's proactive approach to capital management, utilizing proceeds from its recent spin-off to optimize its balance sheet. By repurchasing up to $1.6 billion in debt, the company aims to reduce its overall leverage and potentially lower future interest expenses. This action, alongside the previously announced $2 billion accelerated share repurchase program, signals a strong commitment to enhancing shareholder value and improving financial efficiency. Investors should view this as a positive step in the company's strategic financial restructuring.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BDX was trading at $171.68 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $48.9B. The 52-week trading range was $127.54 to $184.94. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDX - Latest Insights

BDX
Aug 06, 2026, 4:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $177.07
Real-time Price: $176.80 info
Change: -$0.270 (-0.15%) info
Market Cap: $48.158B info
BDX
Aug 06, 2026, 6:51 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $172.00
Real-time Price: $176.80 info
Change: +$4.80 (+3%) info
Market Cap: $48.158B info
BDX
Aug 06, 2026, 6:31 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $172.00
Real-time Price: $176.80 info
Change: +$4.80 (+3%) info
Market Cap: $48.158B info
BDX
Jul 31, 2026, 2:37 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $165.42
Real-time Price: $176.80 info
Change: +$11.39 (+7%) info
Market Cap: $48.158B info
BDX
Jul 29, 2026, 6:54 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $161.25
Real-time Price: $176.80 info
Change: +$15.55 (+10%) info
Market Cap: $48.158B info